The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LMTK3 as a novel regulator of oncogenic KIT in KIT-mutant cancers.
 
Lillian Rose Klug
No Relationships to Disclose
 
Jeffrey Tyner
Consulting or Advisory Role - Leap Oncology
Research Funding - Aptose Biosciences; Array BioPharma; AstraZeneca/MedImmune; Constellation Pharmaceuticals; Genentech; Incyte; Janssen; Seagen; Takeda
 
Michael C. Heinrich
Stock and Other Ownership Interests - MolecularMD
Honoraria - Novartis
Consulting or Advisory Role - ARIAD; Blueprint Medicines; MolecularMD; Novartis; Pfizer
Research Funding - ARIAD (Inst); Arog (Inst); Deciphera (Inst); Inhibikase (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent on treatment of GIST-licensed to Novartis (Inst)
Expert Testimony - Novartis